MIRA INFORM REPORT
|
Report Date : |
04.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
ATLANTA ASSOCIATES |
|
|
|
|
Registered Office : |
Sector No 14, Vashi, Navi Mumbai – 400703, India |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
15.08.1986 |
|
|
|
|
Legal Form : |
Sole Proprietory Concern |
|
|
|
|
Line of Business : |
Manufacturer
and Merchant Exporter of Bulk Drugs & Intermediates and Pharmaceutical
Formulations, etc. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
Maximum Credit Limit : |
USD 56000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established concern having satisfactory track. Trade
relations are fair. Payments are reported as slow but correct. Management declined audited financial statements. The concern can be considered for small to mediocre business dealings
at usual trade terms and conditions.
|
LOCATIONS
|
Registered Office / Factory : |
Sector No 14, Vashi, Navi Mumbai – 400703, India |
|
Area : |
425 sq. ft. |
|
Location : |
Owned |
|
|
|
|
Corporate Office : |
192/4, Pushpa Kunj, Station Road, Wadala
(West), Mumbai – 400 031. India |
|
Tel. No.: |
91-22- 24121784
|
|
Mobile No.: |
91- 9869 200619 |
|
Fax No.: |
91-22-24130709 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
360 sq. ft. |
|
Location : |
Owned – Ground Floor |
SOLE PROPRIETOR
|
Name : |
Mr. Tushar Shah |
|
Designation : |
Proprietor |
|
Date of Birth/Age : |
45 Years |
|
Qualification : |
Graduate |
|
Experience : |
23 Years |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer
and Merchant Exporter of Bulk Drugs & Intermediates and Pharmaceutical Formulations,
etc. |
|
|
|
|
Products : |
Ø Pharmaceutical
formulations-Gener Ø Pharmaceutical
Formulations-Brand Ø Bulk Drugs & Intermediates Ø Organic & Inorganic
Chemicals Ø Laboratory Chemicals Ø Diagnostics Reagents Ø Ayurvedic Medicines Ø Veterinary Medicines Ø Surgical Dressings &
Disposables Ø Essential Oils & Perfumary
Compounds Ø Petroleum Products Ø Spiritious Medicines Ø Baby Products Ø Dental Cartridge Ø Insecticides Ø
General Items |
|
|
|
|
Exports : |
|
|
Countries : |
Taiwan, Nigeria, Jordan, Ghana, Korea, Yemen, Mauritius and Italy |
|
|
|
|
Imports : |
|
|
Products : |
Pharmaceutical Raw Materials |
|
Countries : |
China and Germany |
|
|
|
|
Terms : |
|
|
Selling : |
L/C and Advance Payment 30 % |
|
|
|
|
Purchasing : |
Cash |
GENERAL
INFORMATION
|
Customers : |
Wholesalers and Ministry of Health |
|
|
|
|
No. of Employees : |
15 |
|
|
|
|
Bankers : |
Central Bank of India Wadala West, Mumbai – 400037 |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Kishore Pahari and Associates Chartered Accountants |
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Rs. 14.000 Millions |
|
Borrowed : |
-– |
|
Total : |
Rs. 14.000 Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
|
|
|
31.03.2007 |
31.03.2006 |
|
Sales Turnover |
|
46.500 |
62.000 |
|
|
|
|
|
|
Export Value |
|
46.500 |
62.000 |
|
|
|
|
|
|
Import Value |
|
NA |
NA |
Expected Sales (2007-08) : Rs. 50.000 Millions
LOCAL AGENCY
FURTHER INFORMATION
Trade Reference
Ø
Jim Royal Trading Company, Taiwan
Ø
MSJ Limited, Mauritius
Ø
Arun Trading Company, Jordan
As Per Website
An independent company of professional pharmaceutical traders, ATLANTA ASSOCIATES Manufacturer / Merchant Exporter of Pharmaceutical Formulations, both Brand & Generic names, Bulk Drugs & Intermediates, Surgical Dressings, Organic & Inorganic Chemicals, Veterinary Medicines, etc. founded by a group of experienced experts, entered into trading relationship all over the Globe on 15th August 1986, with a mission to provide world class export services from India to Importers all over the world.
The creation and maintenance of conditions favorable to the development of International exchanges is a priority objective of our organization aimed at boosting the health-care delivery system around the Globe, offering the modest contribution in the International Health Program.
Vast manufacturing resource pool of India on one hand and technoeconomic expertise of our founding members on the other hand, gives us a cutting edge to offer high quality products with attractive prices and other commercial terms. Each member of the team has gained several years of active experience and today, ATLANTA ASSOCIATES stands on the threshold of rapid expansion globally and the future holds the promise of prosperous growth having commitment to be on the ball throughout the Globe.
Ø
Ointment/Cream
Ø
Eye/Ear Drops
Ø
Aerosol Inhaler
Ø Anal Suppositories
Ø
Tablets
Ø
Capsules
Ø
Injections
Ø Syrup/Suspension
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.13 |
|
UK Pound |
1 |
Rs.85.36 |
|
Euro |
1 |
Rs.57.64 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
4 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
37 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|